THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC Test
Are you or someone you know suspected to have thalassemia? DNA Labs UAE offers the THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test, a genetic test that can help diagnose and determine the type and severity of thalassemia.
Test Components
The THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test focuses on analyzing the HBB gene for mutations and variations associated with thalassemia. Thalassemia is a group of inherited blood disorders characterized by abnormal hemoglobin production, leading to anemia.
Price
The cost of the THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test is AED 4100.0.
Sample Condition
To perform the test, you need to submit 3 mL (2 mL minimum) of whole blood (Maternal) in 1 Lavender top (EDTA) tube and 10 mL (5 mL minimum) of amniotic fluid or CVS (Chorionic Villus Sampling) in a sterile screw capped container. The samples should be shipped refrigerated and should not be frozen. Additionally, you need to fill the Prenatal Genetic testing consent form (Form 18) and Genomics Clinical information requisition form (Form 20).
Report Delivery
The sample should be submitted daily by 9 am. The report will be delivered within 21 working days.
Method
The THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test utilizes Next Generation Sequencing and Fragment analysis techniques for accurate and reliable analysis of the beta-globin gene.
Test Type
The THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test falls under the category of Genetic Disorders.
Doctor
The test will be conducted by a Hematologist.
Test Department
The test is performed in the Molecular Diagnostics department.
Pre Test Information
Prior to the test, it is mandatory to fill the Prenatal Genetic testing consent form (Form 18) and Genomics Clinical information requisition form (Form 20).
Test Details
The THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test is a genetic test used to analyze the beta-globin gene for mutations and variations associated with thalassemia. This test can help diagnose and determine the type and severity of thalassemia in an individual.
Thalassemia is a group of inherited blood disorders characterized by abnormal hemoglobin production, leading to anemia. The test specifically focuses on the beta-globin gene, responsible for producing the beta chains of hemoglobin. Mutations or variations in this gene can result in reduced or absent beta-globin production, leading to different types and severities of thalassemia.
The THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test utilizes molecular genetic techniques, including Next Generation Sequencing and Fragment analysis, to identify specific mutations or variations in the beta-globin gene. This information can aid in accurate diagnosis, risk assessment, and personalized treatment planning for individuals with thalassemia.
In addition to diagnosing thalassemia, this test can provide information about carrier status and the risk of passing on thalassemia to future generations. The MCC (Multiplexed Coverage Consensus) technology used in this test allows for highly accurate and reliable analysis of the beta-globin gene, detecting a wide range of known and novel mutations.
Overall, the THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test is a valuable tool for genetic testing and counseling in individuals suspected to have thalassemia or those with a family history of the condition. It can aid in accurate diagnosis, risk assessment, and personalized treatment planning for individuals with thalassemia.
Test Name | THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC Test |
---|---|
Components | HBB gene |
Price | 4100.0 AED |
Sample Condition | Submit 3 mL (2 mL min.) whole blood (Maternal) in 1 Lavender top (EDTA) tube AND 10 mL (5 mL min.) Amniotic fluid \/ CVSin a sterile screw capped container. Ship refrigerated. DO NOT FREEZE. Duly filled Prenatal Genetic testing consent form (Form 18) & Genomics Clinical information requisition form (Form 20) is mandatory. |
Report Delivery | Sample Daily by 9 am; Report 21 Working days |
Method | Next Generation Sequencing, Fragment analysis |
Test type | Genetic Disorders |
Doctor | Hematologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled Prenatal Genetic testing consent form (Form 18) & Genomics Clinical information requisition form (Form 20) is mandatory. |
Test Details |
The THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test is a genetic test that is used to analyze the beta-globin gene for mutations and variations associated with thalassemia. Thalassemia is a group of inherited blood disorders characterized by abnormal hemoglobin production, leading to anemia. The test specifically focuses on the beta-globin gene, which is responsible for producing the beta chains of hemoglobin. Mutations or variations in this gene can result in reduced or absent beta-globin production, leading to different types and severities of thalassemia. The test utilizes molecular genetic techniques to identify specific mutations or variations in the beta-globin gene. This can help in diagnosing and determining the type and severity of thalassemia in an individual. It can also provide information about carrier status and the risk of passing on thalassemia to future generations. The MCC (Multiplexed Coverage Consensus) technology used in this test allows for highly accurate and reliable analysis of the beta-globin gene. It can detect a wide range of known and novel mutations, providing comprehensive genetic information for thalassemia diagnosis and management. Overall, the THALASSEMIA BETA COMPLETE GENE ANALYSIS WITH MCC test is a valuable tool for genetic testing and counseling in individuals suspected to have thalassemia or those with a family history of the condition. It can aid in accurate diagnosis, risk assessment, and personalized treatment planning for individuals with thalassemia. |